Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSerco Regulatory News (SRP)

Share Price Information for Serco (SRP)

Share Price is delayed by 15 minutes
Get Live Data
253.60    -0.20 (-0.08%)
Bid:
253.40
Ask:
253.80
Spread: 0.40 (0.158%)
Market Cap: £2.51b
SRP Live PriceLast checked at - London Stock Exchange

Intraday Serco Share Chart

Director/PDMR Shareholding

13 May 2025 13:00

RNS Number : 4766I
Serco Group PLC
13 May 2025
 

Serco Group plc (the Company)

 

NOTIFICATION OF A TRANSACTION OF A PERSON DISCHARGING MANAGERIAL RESPONSIBILITIES (PDMR)

 

The Company has been notified of the following change in interests in the ordinary shares of 2p each of a PDMR.

 

This announcement is made in accordance with the requirements of the UK version of the Market Abuse Regulation 596/2014. 

 

1

 

Details of the person discharging managerial responsibilities/person closely associated

 

a)

 

Name of natural person

Nigel Crossley

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Group Chief Financial Officer

b)

 

Initial notification/Amendment

 

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Serco Group plc

b)

 

Legal Entity Identifier code

 

 

549300PT2CIHYN5GWJ21

4

 

Details of the transaction(s) summary table

 

Date of Transaction

Financial Instrument

Identification Code

Place of Transaction

Currency

 

12 May 2025

Ordinary shares of 2 pence each

ISIN: GB0007973794

London Stock Exchange, Main Market (XLON)

GBP - British Pound

 

Nature of Transaction

 

 

Price

Volume

Total

 

Dividend Reinvestment Plan 

 

 

£1.745

 

14,938

 

£26,066.81

 

 

Aggregated

£1.745

14,938

£26,066.81

 

 

Nickesha Graham-Burrell

Group Company Secretary

13 May 2025

 

 

For further information please contact:

Jamie Hastings, Group Head of Investor Relations, tel: +44 (0) 7718 195 074 or email: jamie.hastings@serco.com

Scot Marchbank, Group Communications and Marketing Director, tel: +44 (0) 7958 675 706 or email: scot.marchbank@serco.com

 

 

 

About Serco

Serco brings together the right people, the right technology and the right partners to create innovative solutions that make positive impact and address some of the most urgent and complex challenges facing the modern world. With a primary focus on serving governments globally, Serco's services are powered by more than 50,000 people working across defence, space, migration, justice, healthcare, mobility and customer services. Serco's core capabilities include service design and advisory, resourcing, complex programme management, systems integration, case management, engineering, and asset & facilities management. Underpinned by Serco's unique operating model, Serco drives innovation and supports customers from service discovery through to delivery. More information can be found at www.serco.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHUOORRVNUVAAR
Date   Source Headline
31st Mar 20227:00 amRNSTransaction in Own Shares
30th Mar 20223:07 pmRNSDirector/PDMR Shareholding
30th Mar 20227:00 amRNSTransaction in Own Shares
29th Mar 20227:00 amRNSTransaction in Own Shares
28th Mar 20227:00 amRNSTransaction in Own Shares
25th Mar 20227:00 amRNSTransaction in Own Shares
24th Mar 20227:00 amRNSTransaction in Own Shares
23rd Mar 20227:00 amRNSTransaction in Own Shares
22nd Mar 20227:00 amRNSTransaction in Own Shares
21st Mar 20223:41 pmRNSNotice of AGM
21st Mar 20227:00 amRNSTransaction in Own Shares
18th Mar 20227:00 amRNSTransaction in Own Shares
17th Mar 20227:00 amRNSTransaction in Own Shares
16th Mar 20227:00 amRNSTransaction in Own Shares
15th Mar 20227:00 amRNSTransaction in Own Shares
11th Mar 20227:00 amRNSTransaction in Own Shares
10th Mar 20227:00 amRNSTransaction in Own Shares
9th Mar 20227:00 amRNSTransaction in Own Shares
8th Mar 202212:24 pmRNSAnnual Financial Report
8th Mar 20227:00 amRNSShare Repurchase
1st Mar 202210:05 amRNSTotal Voting Rights
24th Feb 20227:00 amRNS2021 Full Year Results
15th Feb 202211:57 amRNSHolding(s) in Company
10th Feb 20229:52 amRNSHolding(s) in Company
1st Feb 20223:30 pmRNSTotal Voting Rights
26th Jan 202210:10 amRNSHolding(s) in Company
24th Jan 20222:51 pmRNSHolding(s) in Company
20th Jan 20221:42 pmRNSHolding(s) in Company
20th Jan 20221:00 pmRNSDirector Declaration
4th Jan 202210:00 amRNSTotal Voting Rights
24th Dec 202111:50 amRNSDirector/PDMR Shareholding
2nd Dec 20217:00 amRNSCapital Markets Event and initial 2022 guidance
1st Dec 202110:00 amRNSTotal Voting Rights
15th Nov 20217:00 amRNSTrading update
1st Nov 20219:39 amRNSTotal Voting Rights
25th Oct 202110:40 amRNSHolding(s) in Company
11th Oct 20213:07 pmRNSDirector Declaration
1st Oct 202110:06 amRNSTotal Voting Rights
24th Sep 202111:11 amRNSDirectorate Change
22nd Sep 20212:38 pmRNSDirector/PDMR Shareholding
1st Sep 20219:51 amRNSTotal Voting Rights
24th Aug 20214:17 pmRNSDirector/PDMR Shareholding
5th Aug 20217:00 amRNSHalf-year Report
2nd Aug 202110:08 amRNSTotal Voting Rights
2nd Jul 20217:00 amRNSDirector/PDMR Shareholding
1st Jul 202110:16 amRNSTotal Voting Rights
30th Jun 20217:00 amRNSClosed period trading update
29th Jun 202110:00 amRNSDirector/PDMR Shareholding
28th Jun 20217:00 amRNSSerco wins Testing Centres contract rebid
28th Jun 20217:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.